| Typicality: | 0.325 |
| Saliency: | 0.176 |
| by a pharmaceutical company | 3 | other |
| trial → be → more likely | 5 |
| trial → be → more likely than those | 4 |
| negative | neutral | positive |
| 0.248 | 0.560 | 0.192 |
| Raw frequency | 9 |
| Normalized frequency | 0.176 |
| Modifier score | 0.500 |
| Perplexity | 90.652 |